Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000974755 | SCV001122611 | benign | Cohen syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002409287 | SCV002674679 | likely benign | Inborn genetic diseases | 2019-01-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003432978 | SCV004158267 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | VPS13B: BP4, BP7 |
Natera, |
RCV000974755 | SCV002082655 | likely benign | Cohen syndrome | 2020-01-20 | no assertion criteria provided | clinical testing |